|
|
|
Volumn 62, Issue 229, 1997, Pages 63268-63269
|
|
Policy on 180-day marketing exclusivity for drugs marketed under abbreviated new drug applications; clarification--FDA. Clarification.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GENERIC DRUG;
ARTICLE;
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
LEGAL ASPECT;
PATENT;
UNITED STATES;
DRUG INDUSTRY;
DRUGS, GENERIC;
INVESTIGATIONAL NEW DRUG APPLICATION;
MARKETING OF HEALTH SERVICES;
PATENTS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0031589630
PISSN: 00976326
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|